Polycystic Ovaries But Not PCOS: The Scan Finding Isn't the Diagnosis

What does “polycystic ovaries” on a scan report actually mean?

It means one measurement — follicle count or ovarian volume — crossed a numeric threshold on that scan, and nothing more than that on its own. Polycystic ovarian morphology (PCOM) is one of three features in the Rotterdam criteria, alongside irregular ovulation and clinical or biochemical hyperandrogenism, and the 2023 international guideline still requires two of those three, plus exclusion of other causes, before PCOS is diagnosed. The task force that defined the ultrasound threshold said this directly: it “recommended against diagnosing PCOS on ultrasound appearance alone,” because that finding by itself was never meant to carry the diagnosis — a 2014 report from the Androgen Excess and PCOS Society treats an ovary meeting the count or volume threshold in someone who ovulates normally, with no excess androgen, as its own separate category, distinct from PCOS.

One naming note, mentioned once: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. The anatomy on the screen and what it does and doesn’t prove did not change with the name. This article uses PCOS because that’s still what most people search.

How common is it to have polycystic-looking ovaries and not have PCOS?

Common enough that the finding alone tells you almost nothing: 32% of normally ovulating women aged 25 to 45, in a community-based ovarian-aging cohort of 262 Caucasian women, met the Rotterdam ultrasound definition for polycystic ovaries by antral follicle count, according to a 2010 study published in the Journal of Clinical Endocrinology & Metabolism. That prevalence fell with age. And beyond the frequency, the same study found the two groups looked metabolically alike: women with PCOM who ovulated normally showed no meaningful difference from women without PCOM on any measured metabolic marker, aside from a slightly higher BMI and waist circumference — the study’s own conclusion states that isolated PCOM in an ovulatory woman “is not an indication for metabolic evaluation.”

Why does the two-of-three rule matter this much for a scan finding specifically?

Because it’s the mechanism that keeps one scan measurement from ever being sufficient by itself. The Rotterdam criteria, agreed in 2003 and still the backbone of the current international guideline, require any two of: irregular or absent ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. Someone with regular, confirmed ovulation and no clinical or biochemical sign of excess androgen has satisfied exactly one leg of that rule no matter what their ovaries look like on a scan — the other two legs are not optional extras, they’re two-thirds of the requirement. What “regular periods” actually rules out explains that half, and the reverse case — normal-looking bloodwork that doesn’t rule PCOS out either — is the same principle from the opposite direction: no single leg of Rotterdam, met or unmet, settles the diagnosis alone.

What actually happens when an incidental scan finding gets treated as a diagnosis?

It turns a measurement into a label, and the label carries consequences the measurement alone never justified. A scan ordered for an unrelated reason — a fertility work-up, a routine pelvic ultrasound, an emergency-department scan for pain — that happens to report “polycystic-appearing ovaries” gets read by a patient, and sometimes by a clinician moving quickly, as a PCOS diagnosis on the spot. From there, three things tend to follow that a single scan finding never supported: a chart entry that follows the person to every future visit and every insurance form; anxiety about fertility that isn’t warranted in someone who is already ovulating regularly, since ovulatory status — not ovarian appearance — is what predicts conception difficulty; and, less often but still documented, a prescription aimed at “PCOS” symptoms — a metformin trial, an inositol recommendation, hormonal contraception framed as PCOS treatment — started without the ovulation and androgen assessment that would have shown it wasn’t indicated.

Has the follicle-count threshold changed, and does that matter for reading an old scan?

Yes — the number that counts as “polycystic” has moved as ultrasound resolution improved, which means an older report and a newer one are not directly comparable. The original 2003 Rotterdam consensus set the bar at 12 or more follicles per ovary, built for the image quality available at the time. A 2013 study using higher-resolution transvaginal probes found that older count caught far too many normal ovaries once modern equipment could resolve smaller follicles, and proposed a much higher threshold — 26 or more — calibrated to that better resolution. The 2023 guideline settled on 20 or more follicles in at least one ovary, using an 8 MHz or higher transvaginal probe, as the current standard. The full follicle-threshold history, with sensitivity and specificity by year goes into that progression in detail — the point for this article is narrower: a follicle count read against the wrong-era threshold, or an old report re-quoted years later as though the number still means the same thing, is not a reliable basis for a diagnosis either way.

Does PCOM ever warrant a closer look, rather than reassurance?

Yes — the reassurance in this article applies specifically to isolated PCOM, not to every scan that mentions the word “polycystic.” If irregular or absent ovulation, or clinical or biochemical hyperandrogenism, is also present, two of the three Rotterdam criteria are now met and PCOS is the correct diagnosis regardless of how the finding was originally discovered. The practical takeaway isn’t “ignore a polycystic-appearing scan” — it’s “a polycystic-appearing scan by itself answers one question out of three,” and the other two are worth actually checking rather than assuming either way.

Does the rule change for teenagers, and if so why?

Yes, and more strictly than for adults: the 2023 guideline states there are “no definitive criteria to define polycystic ovary morphology on ultrasound in adolescents,” so ultrasound is not recommended for diagnosing PCOS in that age group at all. Multi-follicular ovaries are a normal, expected feature of a reproductive system still maturing in the years after a first period, so a finding that would count as PCOM on an adult threshold means even less in a teenager — closer to noise than signal. Anyone with PCOS features who doesn’t yet meet full diagnostic criteria as a teenager is re-assessed later, around eight years post-menarche, rather than diagnosed from a scan in the meantime.

This is one specific, common version of a larger pattern; the six conditions most often mistaken for PCOS covers the rest of it.

Who this doesn’t apply to

This reassurance is specifically for isolated PCOM — a scan finding in someone who ovulates regularly and has no clinical or biochemical excess androgen. It does not apply if you already have irregular or absent ovulation or signs of excess androgen alongside the scan finding: two of three criteria are already met at that point, and the diagnosis stands regardless of how the finding was first noticed. It also doesn’t tell you anything about your own scan specifically — that requires knowing your actual follicle count or volume, which threshold your radiologist applied, and your own ovulation and androgen status, not a population statistic quoted in an article.